Banu Dane

Banu Dane

Auto-generated profile, based on publicly available information

Banu Dane

Department of Perinatology Başakşehir Çam and Sakura City Hospital Istanbul Turkey

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 July 2013 in Gynecological Endocrinology
Verified
Journal Article
Closed access
SASeda Ates
Seda Ates
OSOsman Sevket
Osman Sevket
SSSinem Sudolmus
Sinem Sudolmus
BDBanu Dane
Banu Dane
FOFulya Ozkal
Fulya Ozkal
RDRamazan Dansuk
Ramazan Dansuk
This study presents the differences in clinical, endocrine and metabolic parameters among different polycystic ovary syndrome (PCOS) phenotypes in Turkish women. Four hundred and ten women with PCOS were evaluated, while 97 healthy women served as controls. PCOS were defined by oligo-anovulation (OA), hyperandrogenism (HA) and polycystic ovaries on ultrasound (PCO). Patients were subdivided into four phenotypes: OA + HA + PCO (phenotype 1), OA + HA (phenotype 2), HA + PCO (phenotype 3), OA + PCO (phenotype 4). Phenotypes 1–4 were present in 47.1%, 13.2%, 21.2% and 18.5% of patients, respectively. They were also divided into three groups according to the BMI (30 kg/m2). ANOVA and Tukey post-hoc HSD tests were used. The LH levels and LH/FSH ratio were higher in phenotype 1 and 2 than phenotype 3. The LDL-C levels were higher in women with phenotype 1 and 4 than in women with phenotype 2. Women with BMI <25 kg/m2 had higher levels of LH, LH/FSH ratio, and the HDL-C than other two groups. The levels of TG, LDL, fasting insulin and HOMA-IR increased with increasing BMI in four phenotypes. Results suggest that obesity seems to be the primary cause of metabolic disturbances in PCOS women.

20 April 2026 in International Journal of Gynecology & Obstetrics
Verified
Journal Article
Closed access
HCHale Ozer Caltek
Hale Ozer Caltek
GTGüray Tuna
Güray Tuna
ESESRA SELVI
ESRA SELVI
PDPakizer Banu Kılıçoğlu Dane
Pakizer Banu Kılıçoğlu Dane

1 September 2022 in Black Sea Journal of Health Science
Verified
Journal Article
Closed access
KSKamuran Suman
Kamuran Suman
ZBZafer Bütün
Zafer Bütün
MBMusa Büyük
Musa Büyük
MSMurat Suman
Murat Suman
BDBanu Dane
Banu Dane
In this study, we aimed to investigate whether there was an association between fetal nuchal translucency (NT) and the serum markers plasma protein-A (PAPP-A) and free beta-human chorionic gonadotropin (β-hCG) measured by the first-trimester screening test, as well as birth weight and hypertension. 454 pregnant women who had undergone the first-trimester screening test for Down syndrome were included in the study. All measurements and values of NT, PAPP-A and β-hCG levels were performed between gestational weeks 11-14. Values of PAPP-A and β-hCG converted to multiples of the corrected median (MoM) were obtained using the PRISCA software package. Regarding the prediction of SGA infants, when the PAPP-A value < was 0.99MoM as a threshold, and when the free β-hCG value < was 0.69 MoM, SGA cases could be detected with a sensitivity of 83% and a specificity of 71.9%. Regarding the prediction of hypertension, at a threshold PAPP-A value of

1 April 2024 in Bezmialem Science
Verified
Journal Article
Closed access
MMMustafa Maraşli
Mustafa Maraşli
EKESRA KELES
ESRA KELES
PYPınar Yildiz
Pınar Yildiz
MKMehmet Mete Kırlangıç
Mehmet Mete Kırlangıç
RTRezzan BERNA Temoçin
Rezzan BERNA Temoçin
BDBanu Dane
Banu Dane